REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medilink SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medilink SIA Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Medilink SIA is based in Latvia. The head office is in Riga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on February 27, 2008. It currently has a total number of 50 (2023) employees. From the latest financial highlights, Medilink SIA reported a net sales revenue increase of 8.82% in 2024. Its’ total assets recorded a negative growth of 3.37%. Medilink SIA’s net profit margin increased by 8.07% in 2024.

Headquarters
Visku iela 2 k-1
Riga; Riga; Postal Code: 1063

Contact Details: Purchase the Medilink SIA report to view the information.

Basic Information
Total Employees:
Purchase the Medilink SIA report to view the information.
Registered Capital:
Purchase the Medilink SIA report to view the information.
Financial Auditors:
Purchase the Medilink SIA report to view the information.
Incorporation Date:
February 27, 2008
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
28%
Purchase this report to view the information.
22%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Medilink SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
8.82%▲
Total Operating Revenue
9.41%▲
Operating Profit
49.73%▲
EBITDA
49.73%▲
Net Profit/Loss for the Period
48.75%▲
Total Assets
-3.37%▼
Total Equity
-8.84%▼
Operating Profit Margin
8.06%▲
Net Profit Margin
8.07%▲
Return on Equity (ROE)
7.55%▲
Quick Ratio
0%
Cash Ratio
-0.09%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo